fMRI-Directed rTMS Targeting V1 Alleviates Depressive Symptoms in Young Individuals with Bipolar Disorder: Results from a Double-Blind Randomized Controlled Study - Takeaways - MDSpire

fMRI-Directed rTMS Targeting V1 Alleviates Depressive Symptoms in Young Individuals with Bipolar Disorder: Results from a Double-Blind Randomized Controlled Study

  • By

  • Xudong Zhao

  • Hetong Zhou

  • Xiaomei Zhang

  • Ruoyu Tang

  • Yimei Gan

  • Tongjie Zhuang

  • Yiyi Zhu

  • Zeyu Qin

  • Yiqing Chen

  • Yaoyang Fu

  • Danhua Zhang

  • Le Xu

  • Shiliang Wang

  • Zhongxia Shen

  • Shaohua Hu

  • Minmin Wang

  • March 7, 2026

  • 0 min

Share

  • 1

    Bipolar disorder in young individuals significantly disrupts emotional regulation and psychosocial functioning, necessitating effective treatment options.

  • 2

    Repetitive transcranial magnetic stimulation (rTMS) targeting the orbitofrontal cortex has shown promise in alleviating treatment-resistant depression.

  • 3

    This study utilized fMRI-guided high-frequency rTMS over the primary visual cortex (V1) to indirectly modulate orbitofrontal cortex circuits.

  • 4

    A double-blind, randomized controlled trial was conducted to evaluate the efficacy of V1-targeted rTMS in reducing depressive symptoms.

  • 5

    Results indicated significant improvements in depression scores, suggesting V1-targeted rTMS may be a viable treatment for bipolar depression.

Original Source(s)

Related Content